Cybin Inc. (NEO: CYBN.NE) Stock Competitors & Peer Comparison

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, LLY.TO has a market cap of 1.5T. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while LLY.TO trades at CA$42.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas LLY.TO's P/E ratio is 39.27. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to LLY.TO's ROE of N/A. Regarding short-term risk, CYBN.NE is more volatile compared to LLY.TO. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check LLY.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, NBLY.TO has a market cap of 835.5M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while NBLY.TO trades at CA$18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas NBLY.TO's P/E ratio is -25.48. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to NBLY.TO's ROE of -0.03%. Regarding short-term risk, CYBN.NE is more volatile compared to NBLY.TO. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check NBLY.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, MDP.TO has a market cap of 159.6M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while MDP.TO trades at CA$5.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas MDP.TO's P/E ratio is -53.31. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to MDP.TO's ROE of -0.05%. Regarding short-term risk, CYBN.NE is more volatile compared to MDP.TO. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check MDP.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, NOVC.TO has a market cap of 108M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while NOVC.TO trades at CA$1.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas NOVC.TO's P/E ratio is 34.80. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to NOVC.TO's ROE of +0.06%. Regarding short-term risk, CYBN.NE is more volatile compared to NOVC.TO. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check NOVC.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, CBST.NE has a market cap of 17.5M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while CBST.NE trades at CA$0.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas CBST.NE's P/E ratio is -0.05. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to CBST.NE's ROE of +1.07%. Regarding short-term risk, CYBN.NE is more volatile compared to CBST.NE. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check CBST.NE's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, FAF.TO has a market cap of 13.1M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while FAF.TO trades at CA$0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas FAF.TO's P/E ratio is -0.14. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to FAF.TO's ROE of -0.97%. Regarding short-term risk, CYBN.NE is less volatile compared to FAF.TO. This indicates lower risk in terms of short-term price fluctuations for CYBN.NE.Check FAF.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, GABY.CN has a market cap of 3.7M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while GABY.CN trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas GABY.CN's P/E ratio is -0.08. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to GABY.CN's ROE of +3.03%. Regarding short-term risk, CYBN.NE is more volatile compared to GABY.CN. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check GABY.CN's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, CSCI.TO has a market cap of 2.7M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while CSCI.TO trades at CA$7.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas CSCI.TO's P/E ratio is -0.25. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to CSCI.TO's ROE of -0.93%. Regarding short-term risk, CYBN.NE is more volatile compared to CSCI.TO. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check CSCI.TO's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, IWIN.CN has a market cap of 1M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while IWIN.CN trades at CA$0.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas IWIN.CN's P/E ratio is -0.05. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to IWIN.CN's ROE of -0.21%. Regarding short-term risk, CYBN.NE is more volatile compared to IWIN.CN. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check IWIN.CN's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, TREE.NE has a market cap of 1M. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while TREE.NE trades at CA$0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas TREE.NE's P/E ratio is -0.17. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to TREE.NE's ROE of -4.86%. Regarding short-term risk, CYBN.NE is more volatile compared to TREE.NE. This indicates higher risk in terms of short-term price fluctuations for CYBN.NE.Check TREE.NE's competition here

Cybin Inc. (NEO: CYBN.NE) plays a significant role within the Healthcare sector. Its performance on the NEO reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CYBN.NE stands at 256.6M. In comparison, MOOD.CN has a market cap of 877.6K. Regarding current trading prices, CYBN.NE is priced at CA$10.84 on the NEO, while MOOD.CN trades at CA$0.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CYBN.NE currently has a P/E ratio of -2.05, whereas MOOD.CN's P/E ratio is -6.03. In terms of profitability, CYBN.NE's ROE is -0.72%, compared to MOOD.CN's ROE of -0.85%. Regarding short-term risk, CYBN.NE is less volatile compared to MOOD.CN. This indicates lower risk in terms of short-term price fluctuations for CYBN.NE.Check MOOD.CN's competition here